Different sampling time points and Blinding [Bioanalytics]

posted by Pharma_88 – India, 2020-12-11 06:22 (1404 d 07:24 ago) – Posting: # 22138
Views: 3,001

Dear all,

Please provide your suggestion for below concern.

for the bioequivalence studies, Analyst is always blind despite of regulatory requirement. By keeping different sampling time points i.e. 20 time-points for test and 22 time points for reference, whether analyst will blind in this condition?


Edit: Category changed; see also this post #1[Helmut]

Regards,
Pharma_88

Complete thread:

UA Flag
Activity
 Admin contact
23,258 posts in 4,886 threads, 1,671 registered users;
73 visitors (0 registered, 73 guests [including 15 identified bots]).
Forum time: 14:47 CEST (Europe/Vienna)

Tortured data will confess to anything.    Fredric Menger

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5